Skip to main content
Gut logoLink to Gut
. 2001 Mar;48(3):304–309. doi: 10.1136/gut.48.3.304

Secular trends in the epidemiology and outcome of Barrett's oesophagus in Olmsted County, Minnesota

M Conio 1, A Cameron 1, Y Romero 1, C Branch 1, C Schleck 1, L Burgart 1, A Zinsmeister 1, L Melton 1, G Locke 1
PMCID: PMC1760138  PMID: 11171817

Abstract

BACKGROUND—The incidence of oesophageal adenocarcinoma has increased greatly. Barrett's oesophagus is a known risk factor.
AIMS—To identify changes in the incidence, prevalence, and outcome of Barrett's oesophagus in a defined population.
SUBJECTS—Residents of Olmsted County, Minnesota, with clinically diagnosed Barrett's oesophagus, or oesophageal or oesophagogastric junction adenocarcinoma.
METHODS—Cases were identified using the Rochester Epidemiology Project medical records linkage system. Records were reviewed with follow up to 1 January 1998.
RESULTS—The incidence of clinically diagnosed Barrett's oesophagus (>3 cm) increased 28-fold from 0.37/100 000 person years in 1965-69 to 10.5/100 000 in 1995-97. Of note, gastroscopic examinations increased 22-fold in this same time period. The prevalence of diagnosed Barrett's oesophagus increased from 22.6 (95% confidence interval (CI) 11.7-33.6) per 100 000 in 1987 to 82.6/100 000 in 1998. The prevalence of short segment Barrett's oesophagus (<3 cm) in 1998 was 33.4/ 100 000. Patients with Barrett's oesophagus had shorter than expected survival but only one patient with Barrett's oesophagus died from adenocarcinoma. Only four of 64 adenocarcinomas occurred in patients with previously known Barrett's oesophagus.
CONCLUSIONS—The incidence and prevalence of clinically diagnosed Barrett's oesophagus have increased in parallel with the increased use of endoscopy. We infer that the true population prevalence of Barrett's oesophagus has not changed greatly, although the incidence of oesophageal adenocarcinoma increased 10-fold. Many adenocarcinomas occurred in patients without a previous diagnosis of Barrett's oesophagus, suggesting that many people with this condition remain undiagnosed in the community.


Keywords: Barrett's oesophagus; oesophageal adenocarcinoma; adenocarcinoma of cardia; epidemiology; gastroscopy; gastro-oesophageal reflux disease

Full Text

The Full Text of this article is available as a PDF (128.2 KB).

Figure 1  .

Figure 1  

Incidence of new diagnosis of Barrett's oesophagus (BO) and short segment Barrett's oesophagus (SSBO) in Olmsted County residents, 1965-97. Also shown is the annual utilisation rate for upper gastrointestinal endoscopy in the same population.

Figure 2  .

Figure 2  

Survival of 117 Olmsted County residents with Barrett's oesophagus (3 cm or longer) was less than expected for the US white population of similar age and sex (p=0.0006). Numbers at risk are shown.

Figure 3  .

Figure 3  

Incidence of adenocarcinoma of the oesophagus and oesophagogastric junction in Olmsted County residents, 1965-97.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALLISON P. R., JOHNSTONE A. S. The oesophagus lined with gastric mucous membrane. Thorax. 1953 Jun;8(2):87–101. doi: 10.1136/thx.8.2.87. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Begg C. B., Cramer L. D., Hoskins W. J., Brennan M. F. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998 Nov 25;280(20):1747–1751. doi: 10.1001/jama.280.20.1747. [DOI] [PubMed] [Google Scholar]
  3. Black W. C., Welch H. G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993 Apr 29;328(17):1237–1243. doi: 10.1056/NEJM199304293281706. [DOI] [PubMed] [Google Scholar]
  4. Blaser M. J. Hypothesis: the changing relationships of Helicobacter pylori and humans: implications for health and disease. J Infect Dis. 1999 Jun;179(6):1523–1530. doi: 10.1086/314785. [DOI] [PubMed] [Google Scholar]
  5. Blot W. J., Devesa S. S., Kneller R. W., Fraumeni J. F., Jr Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991 Mar 13;265(10):1287–1289. [PubMed] [Google Scholar]
  6. Bytzer P., Christensen P. B., Damkier P., Vinding K., Seersholm N. Adenocarcinoma of the esophagus and Barrett's esophagus: a population-based study. Am J Gastroenterol. 1999 Jan;94(1):86–91. doi: 10.1111/j.1572-0241.1999.00776.x. [DOI] [PubMed] [Google Scholar]
  7. Cameron A. J., Carpenter H. A. Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol. 1997 Apr;92(4):586–591. [PubMed] [Google Scholar]
  8. Cameron A. J., Lomboy C. T., Pera M., Carpenter H. A. Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology. 1995 Nov;109(5):1541–1546. doi: 10.1016/0016-5085(95)90642-8. [DOI] [PubMed] [Google Scholar]
  9. Cameron A. J., Zinsmeister A. R., Ballard D. J., Carney J. A. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology. 1990 Oct;99(4):918–922. doi: 10.1016/0016-5085(90)90607-3. [DOI] [PubMed] [Google Scholar]
  10. Chow W. H., Blot W. J., Vaughan T. L., Risch H. A., Gammon M. D., Stanford J. L., Dubrow R., Schoenberg J. B., Mayne S. T., Farrow D. C. Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1998 Jan 21;90(2):150–155. doi: 10.1093/jnci/90.2.150. [DOI] [PubMed] [Google Scholar]
  11. Chow W. H., Finkle W. D., McLaughlin J. K., Frankl H., Ziel H. K., Fraumeni J. F., Jr The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA. 1995 Aug 9;274(6):474–477. [PubMed] [Google Scholar]
  12. Devesa S. S., Blot W. J., Fraumeni J. F., Jr Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer. 1998 Nov 15;83(10):2049–2053. [PubMed] [Google Scholar]
  13. Drewitz D. J., Sampliner R. E., Garewal H. S. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol. 1997 Feb;92(2):212–215. [PubMed] [Google Scholar]
  14. Gammon M. D., Schoenberg J. B., Ahsan H., Risch H. A., Vaughan T. L., Chow W. H., Rotterdam H., West A. B., Dubrow R., Stanford J. L. Tobacco, alcohol, and socioeconomic status and adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst. 1997 Sep 3;89(17):1277–1284. doi: 10.1093/jnci/89.17.1277. [DOI] [PubMed] [Google Scholar]
  15. Hamilton S. R., Smith R. R., Cameron J. L. Prevalence and characteristics of Barrett esophagus in patients with adenocarcinoma of the esophagus or esophagogastric junction. Hum Pathol. 1988 Aug;19(8):942–948. doi: 10.1016/s0046-8177(88)80010-8. [DOI] [PubMed] [Google Scholar]
  16. Lagergren J., Bergström R., Lindgren A., Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825–831. doi: 10.1056/NEJM199903183401101. [DOI] [PubMed] [Google Scholar]
  17. Lagergren J., Bergström R., Nyrén O. Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med. 1999 Jun 1;130(11):883–890. doi: 10.7326/0003-4819-130-11-199906010-00003. [DOI] [PubMed] [Google Scholar]
  18. Locke G. R., 3rd, Talley N. J., Fett S. L., Zinsmeister A. R., Melton L. J., 3rd Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997 May;112(5):1448–1456. doi: 10.1016/s0016-5085(97)70025-8. [DOI] [PubMed] [Google Scholar]
  19. Mann N. S., Tsai M. F., Nair P. K. Barrett's esophagus in patients with symptomatic reflux esophagitis. Am J Gastroenterol. 1989 Dec;84(12):1494–1496. [PubMed] [Google Scholar]
  20. Melton L. J., 3rd History of the Rochester Epidemiology Project. Mayo Clin Proc. 1996 Mar;71(3):266–274. doi: 10.4065/71.3.266. [DOI] [PubMed] [Google Scholar]
  21. Melton L. J., 3rd The threat to medical-records research. N Engl J Med. 1997 Nov 13;337(20):1466–1470. doi: 10.1056/NEJM199711133372012. [DOI] [PubMed] [Google Scholar]
  22. Menke-Pluymers M. B., Schoute N. W., Mulder A. H., Hop W. C., van Blankenstein M., Tilanus H. W. Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut. 1992 Nov;33(11):1454–1458. doi: 10.1136/gut.33.11.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Naef A. P., Savary M. Conservative operations for peptic esophagitis with stenosis in columnar-lined lower esophagus. Ann Thorac Surg. 1972 Jun;13(6):543–551. doi: 10.1016/s0003-4975(10)65171-5. [DOI] [PubMed] [Google Scholar]
  24. Nebel O. T., Fornes M. F., Castell D. O. Symptomatic gastroesophageal reflux: incidence and precipitating factors. Am J Dig Dis. 1976 Nov;21(11):953–956. doi: 10.1007/BF01071906. [DOI] [PubMed] [Google Scholar]
  25. O'Connor J. B., Falk G. W., Richter J. E. The incidence of adenocarcinoma and dysplasia in Barrett's esophagus: report on the Cleveland Clinic Barrett's Esophagus Registry. Am J Gastroenterol. 1999 Aug;94(8):2037–2042. doi: 10.1111/j.1572-0241.1999.01275.x. [DOI] [PubMed] [Google Scholar]
  26. Pera M., Cameron A. J., Trastek V. F., Carpenter H. A., Zinsmeister A. R. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology. 1993 Feb;104(2):510–513. doi: 10.1016/0016-5085(93)90420-h. [DOI] [PubMed] [Google Scholar]
  27. Prach A. T., MacDonald T. A., Hopwood D. A., Johnston D. A. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet. 1997 Sep 27;350(9082):933–933. doi: 10.1016/S0140-6736(05)63269-2. [DOI] [PubMed] [Google Scholar]
  28. Provenzale D., Kemp J. A., Arora S., Wong J. B. A guide for surveillance of patients with Barrett's esophagus. Am J Gastroenterol. 1994 May;89(5):670–680. [PubMed] [Google Scholar]
  29. Provenzale D., Schmitt C., Wong J. B. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk. Am J Gastroenterol. 1999 Aug;94(8):2043–2053. doi: 10.1111/j.1572-0241.1999.01276.x. [DOI] [PubMed] [Google Scholar]
  30. Sampliner R. E. Practice guidelines on the diagnosis, surveillance, and therapy of Barrett's esophagus. The Practice Parameters Committee of the American College of Gastroenterology. Am J Gastroenterol. 1998 Jul;93(7):1028–1032. doi: 10.1111/j.1572-0241.1998.00362.x. [DOI] [PubMed] [Google Scholar]
  31. Schnell T. G., Sontag S. J., Chejfec G. Adenocarcinomas arising in tongues or short segments of Barrett's esophagus. Dig Dis Sci. 1992 Jan;37(1):137–143. doi: 10.1007/BF01308357. [DOI] [PubMed] [Google Scholar]
  32. Sharma P., Morales T. G., Sampliner R. E. Short segment Barrett's esophagus--the need for standardization of the definition and of endoscopic criteria. Am J Gastroenterol. 1998 Jul;93(7):1033–1036. doi: 10.1111/j.1572-0241.1998.00324.x. [DOI] [PubMed] [Google Scholar]
  33. Spechler S. J., Goyal R. K. Barrett's esophagus. N Engl J Med. 1986 Aug 7;315(6):362–371. doi: 10.1056/NEJM198608073150605. [DOI] [PubMed] [Google Scholar]
  34. Trudgill N. J., Suvarna S. K., Kapur K. C., Riley S. A. Intestinal metaplasia at the squamocolumnar junction in patients attending for diagnostic gastroscopy. Gut. 1997 Nov;41(5):585–589. doi: 10.1136/gut.41.5.585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Tytgat G. N. Does endoscopic surveillance in esophageal columnar metaplasia (Barrett's esophagus) have any real value? Endoscopy. 1995 Jan;27(1):19–26. doi: 10.1055/s-2007-1005627. [DOI] [PubMed] [Google Scholar]
  36. Voutilainen M., Färkkilä M., Juhola M., Nuorva K., Mauranen K., Mäntynen T., Kunnamo I., Mecklin J. P., Sipponen P. Specialized columnar epithelium of the esophagogastric junction: prevalence and associations. The Central Finland Endoscopy Study Group. Am J Gastroenterol. 1999 Apr;94(4):913–918. doi: 10.1111/j.1572-0241.1999.986_i.x. [DOI] [PubMed] [Google Scholar]
  37. Weinstein W. M., Ippoliti A. F. The diagnosis of Barrett's esophagus: goblets, goblets, goblets. Gastrointest Endosc. 1996 Jul;44(1):91–95. doi: 10.1016/s0016-5107(96)70239-0. [DOI] [PubMed] [Google Scholar]
  38. Williamson W. A., Ellis F. H., Jr, Gibb S. P., Shahian D. M., Aretz H. T., Heatley G. J., Watkins E., Jr Barrett's esophagus. Prevalence and incidence of adenocarcinoma. Arch Intern Med. 1991 Nov;151(11):2212–2216. doi: 10.1001/archinte.151.11.2212. [DOI] [PubMed] [Google Scholar]
  39. Winters C., Jr, Spurling T. J., Chobanian S. J., Curtis D. J., Esposito R. L., Hacker J. F., 3rd, Johnson D. A., Cruess D. F., Cotelingam J. D., Gurney M. S. Barrett's esophagus. A prevalent, occult complication of gastroesophageal reflux disease. Gastroenterology. 1987 Jan;92(1):118–124. [PubMed] [Google Scholar]
  40. van Sandick J. W., van Lanschot J. J., Kuiken B. W., Tytgat G. N., Offerhaus G. J., Obertop H. Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut. 1998 Aug;43(2):216–222. doi: 10.1136/gut.43.2.216. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. van der Burgh A., Dees J., Hop W. C., van Blankenstein M. Oesophageal cancer is an uncommon cause of death in patients with Barrett's oesophagus. Gut. 1996 Jul;39(1):5–8. doi: 10.1136/gut.39.1.5. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES